Showing results (611-620 of 658) with videos related to
Sort By:
Pageof 66
Journal of Mood and Anxiety Disorders|January 22, 2026
Familial risk for bipolar disorder, childhood trauma and anxiety in youth: Behavioral approach and inhibition systems as mediators of riskEvangelia Argyriou, Jorge R C Almeida, Melissa P DelBello, et al.Advanced Materials (Deerfield Beach, Fla.)|May 30, 2024
Mucus-Inspired Self-Healing Hydrogels: A Protective Barrier for Cells against Viral InfectionRaju Bej, Corey Alfred Stevens, Chuanxiong Nie, et al.Journal of Patient Safety|June 30, 2017
Description and Yield of Current Quality and Safety Review in Selected US Academic Emergency DepartmentsRichard Thomas Griffey, Ryan M Schneider, Brian R Sharp, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 28, 2018
Discrete patterns of cortical thickness in youth with bipolar disorder differentially predict treatment response to quetiapine but not lithiumWenjing Zhang, Yuan Xiao, Huaiqiang Sun, et al.Journal of Affective Disorders|June 10, 2023
Morphological abnormalities in youth with bipolar disorder and their relationship to clinical characteristicsWenbin Li, Du Lei, Maxwell J Tallman, et al.The American Journal of Gastroenterology|May 14, 2025
The Effectiveness of Forceps-Assisted Cannulation for Difficult Cannulation During Endoscopic Retrograde Cholangiopancreatography: Results of the SOCCER Randomized Controlled TrialSteven M Hadley, Jessica I Chevalier, Grace E Tomasetti, et al.Rheumatology (Oxford, England)|November 23, 2007
Sjögren's Systemic Clinical Activity Index (SCAI)--a systemic disease activity measure for use in clinical trials in primary Sjögren's syndromeS J Bowman, N Sutcliffe, D A Isenberg, et al.Journal of the American Academy of Child and Adolescent Psychiatry|May 29, 2012
Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy studyJeffrey R Strawn, Nick C Patel, Wen-Jang Chu, et al.Journal of Viral Hepatitis|November 25, 2003
Daily induction combination treatment with alpha 2b interferon and ribavirin or standard combination treatment in naive chronic hepatitis C patients. A multicentre randomized controlled trialH Van Vlierberghe, G Leroux-Roels, M Adler, et al.Psychological Medicine|April 8, 2022
Brain morphometric features predict medication response in youth with bipolar disorder: a prospective randomized clinical trialDu Lei, Kun Qin, Wenbin Li, et al.Pageof 66